AstraZeneca Begins Tender Offer To Acquire Cincor Pharma, Inc.
January 24, 2023
January 24, 2023
WILMINGTON, Delaware, Jan. 24 -- AstraZeneca, a biopharmaceutical company, issued the following news release on Jan. 23, 2023:
AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor), for $26 per share in cash at closing, plus a non-tradable contingent value right of $10 per share in cash payable upon a specified regulatory submission for a baxdrostat product. On 9 January 2023, AstraZeneca announced th . . .
AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor), for $26 per share in cash at closing, plus a non-tradable contingent value right of $10 per share in cash payable upon a specified regulatory submission for a baxdrostat product. On 9 January 2023, AstraZeneca announced th . . .